MedPath

DiGESTnewborn Study

Recruiting
Conditions
GDM
Hypoglycemia
Registration Number
NCT04192422
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Brief Summary

We wish to study the effect of a mothers sugar (glucose) control during pregnancy on her baby's sugar control after birth.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • mothers and their babies who have been enrolled in DiGest Trial and who have provided informed consent
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Neonatal sensor glucose time in targetFrom sensor insertion for up to the first 7 days of life

Time sensor glucose levels in target in the first week of life

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Addenbrookes Hospital

🇬🇧

Cambridge, United Kingdom

Addenbrookes Hospital
🇬🇧Cambridge, United Kingdom
Kathryn Beardsall, FRCPCH
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.